Back to Bank of New York Mellon Corp Bank of New York Mellon Corp

FPRXFPRX
8 quarters

Position history for Bank of New York Mellon CorpBank of New York Mellon Corp's holdings in FIVE PRIME THERAPEUTICS INC

As of its Q1 2021 13F, Bank of New York Mellon held 187,963 shares of FPRX (Five Prime Therapeutics), worth $7.1M. Bank of New York Mellon's 13F filings listed FPRX from Q3 2019 to Q1 2021, 7 quarterly filings.

Final Value

$0

Final Shares

0

Total Value Change

-$612,000

Total Shares Change

-157,945

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2021-Q2
Latest
Exited
0
-100.0%
$00.0%—
0
2021-Q1
Increased
187,963
+8.0%
$7.1M0.0%—
30
2020-Q4
Increased
173,996
+43.1%
$3M0.0%—
35
2020-Q3
Decreased
121,553
-1.6%
$572,0000.0%—
0
2020-Q2
Decreased
123,526
-11.9%
$753,0000.0%—
0
2020-Q1
Increased
140,142
+8.3%
$318,0000.0%—
25
2019-Q4
Decreased
129,354
-18.1%
$594,0000.0%—
0
2019-Q3
First report
157,945
-
$612,0000.0%—
0

Other major holders of FPRX: Magnetar Financial LLC, RA CAPITAL MANAGEMENT, L.P., STATE STREET CORP, DIMENSIONAL FUND ADVISORS LP, RTW INVESTMENTS, LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used